Drug approvals

Most Recent

Medicare copays for new Alzheimer’s drug could reach $11,500

By RICARDO ALONSO-ZALDIVAR and MATTHEW PERRONEJune 11, 2021 GMT

WASHINGTON (AP) — A new $56,000-a-year Alzheimer’s drug would raise Medicare premiums broadly, and some patients who are prescribed the medication could face copayments of about $11,500 annually, according to a research report published Thursday.

Keeps Review - Do Keeps Hair Loss Treatments Work? (Keeps.com Review)

Perform InsiderNovember 6, 2020 GMT

New York, New York - ( NewMediaWire ) - November 06, 2020 - Keeps is an online-only subscription service that specializes in treating male baldness. The company offers two of the most popular anti-hair loss medications that are also approved by the FDA...

FDA says Novartis withheld data problem before drug approval

By LINDA A. JOHNSONAugust 6, 2019 GMT

TRENTON, N.J. (AP) — U.S. regulators want to know why Novartis didn't disclose a problem with testing data until after the Swiss drugmaker's $2...